Bilateral Erector Spinae Plane Block for Postoperative Chronic Pain After Open Heart Surgery
CompletedNot applicableNCT06315959
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The aim of this study is to investigate the effect of bilateral erector spinae plane (ESP) block application on postoperative chronic pain in patients undergoing on-pump open-heart surgery. At 3 months post-discharge, patients will be contacted by phone to assess their chronic pain status. Pain intensity and status will be evaluated using the Brief Pain Inventory, and the character of pain will be assessed using the Douleur Neuropathique 4 (DN4) score. Additionally, the patient's anxiety and depression status will be evaluated using the Hospital Anxiety and Depression Scale.
Study details
- Official title
- Bilateral Ultrasound-guided Erector Spinae Plane Block for Postoperative Chronic Pain Following Open Heart Surgery: A Prospective Randomized Controlled Trial
- Conditions
- Chronic Pain
- Cardiac Surgery
- Post Operative Pain
- Interventions
- Procedure: Bilateral ultrasound guided erector spinae plane block
- Drug: morphine PCA
- Other: Control group
- Drug: morphine PCA
- Sponsor
- Ondokuz Mayıs University
- Start date
- 2024-04-01
- Primary completion
- 2024-11-01
- Sex
- All
- Age range
- from 18 Years to 80 Years
- Results posted
- No results posted in this snapshot
- Countries
- Turkey (Türkiye)
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Patients aged 18-80 undergoing elective on-pump open-heart surgery via median sternotomy. * American Society of Anesthesiologists (ASA)classification II-III patients. * Patients who can use PCA. * Patients who will sign the informed consent form. Exclusion Criteria: * History of opioid use for more than four weeks * Chronic pain syndromes * Patients with a history of local anesthetic or opioid allergy, hypersensitivity * Alcohol and drug addiction * Conditions where regional anesthesia is contraindicated * Failure in the dermatomal examination performed after the block * Emergency surgeries and redo surgeries. * Individuals with obstructive sleep apnea. * Left ventricular ejection fraction less than 30%. * Patients with severe psychiatric illnesses (such as psychosis, dementia) that limit cooperation with verbal numerical pain scales. * Pregnant and breastfeeding patients. * Hematological disorders. * Significant impairment in the function of a major organ (e.g., severe hepatic or renal disease). * Patients who cannot be extubated within the first 6 hours postoperatively.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06315959